Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reverse Remodeling is Associated With Hemodynamic Improvement and Stabilization in Outpatients With Heart Failure With Reduced Ejection Fraction Treated With Sacubitril/Valsartan: an Echocardiographic Study

NCT04397302 is registered in ClinicalTrials.gov with Italian Society of Cardiology as lead sponsor.

NCT NCT04397302
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04397302 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reverse Remodeling is Associated With Hemodynamic Improvement and Stabilization in Outpatients With Heart Failure With Reduced Ejection Fraction Treated With Sacubitril/Valsartan: an Echocardiographic Study
Lead sponsor
Italian Society of Cardiology
Phase
Observational
Overall status
Completed
Start date
January 13, 2019
Completion date
March 16, 2020
Enrollment
652 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure, left sided, left ventricular dysfunction, ventricular remodeling